 Home > Medical News > Latest Medical News > Zhenhe Technology joins hands with Imona Medical to jointly develop mRNA tumor vaccines

Zhenhe Technology joins hands with Imona Medical to jointly develop mRNA tumor vaccines

 Last Update: 2021-10-23
 Source: Internet
 Author: User

Tags

veterinary pharmaceutical companies

education technology

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Wuxi, September 16, 2021/PRNewswire/ - On September 16, Wuxi Zhenhe Biotechnology Co.

The mRNA platform has shown superior performance in the new crown vaccine

Mr.

There is currently no mRNA tumor vaccine based on tumor neoantigens in China, which is a new field that needs to be explored urgently

About Zhenhe Technology

Zhenhe Technology was established in Beijing in 2014 and is headquartered in Wuxi, Jiangsu Province.

As a national high-tech enterprise with a technical acceptance certificate of clinical gene amplification testing laboratory issued by the government clinical testing center, and officially licensed to carry out "tumor-related gene projects (regular ARMS method and NGS method)", Zhenhe Technology is the second generation Sequencing technology and bioinformatics are the core, committed to providing the most professional and accurate diagnosis for companies, doctors and patients in the field of cancer diagnosis and treatment, and becoming a trusted decision-making partner in the process of cancer diagnosis and treatment; finally through the application of genetic testing and real-world clinical data , To connect pharmaceutical companies, doctors and patients, and realize the vision of "persisting in technological breakthroughs and application transformation, achieving medical evolution and a healthy future"

About Imona Medical

Imona Medical was established in June 2021.

Source: Zhenhe Technology

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.